vs
Rocket Companies, Inc.（RKT）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Rocket Companies, Inc.的季度营收约是Steris的1.8倍（$2.7B vs $1.5B），Steris净利率更高（12.9% vs 2.5%，领先10.4%），Rocket Companies, Inc.同比增速更快（52.2% vs 9.2%），Steris自由现金流更多（$199.5M vs $-1.3B），过去两年Rocket Companies, Inc.的营收复合增速更高（39.5% vs 15.8%）
Rocket Companies, Inc.是美国金融科技及住房服务企业，由丹·吉尔伯特创立，总部位于密歇根州底特律市中心。公司依托旗舰子公司Rocket Mortgage跻身美国最大抵押贷款提供商行列，旗下还拥有Redfin、Forsalebyowner.com、Rocket Money等子品牌。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
RKT vs STE — 直观对比
营收规模更大
RKT
是对方的1.8倍
$1.5B
营收增速更快
RKT
高出43.0%
9.2%
净利率更高
STE
高出10.4%
2.5%
自由现金流更多
STE
多$1.5B
$-1.3B
两年增速更快
RKT
近两年复合增速
15.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.7B | $1.5B |
| 净利润 | $68.0M | $192.9M |
| 毛利率 | — | 43.8% |
| 营业利润率 | 6.3% | 18.3% |
| 净利率 | 2.5% | 12.9% |
| 营收同比 | 52.2% | 9.2% |
| 净利润同比 | 100.8% | 11.2% |
| 每股收益（稀释后） | $0.10 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RKTSTE
| Q4 25 | $2.7B | $1.5B | ||
| Q3 25 | $1.6B | $1.5B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $1.8B | $1.4B | ||
| Q3 24 | $646.9M | $1.3B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.4B | $1.1B |
净利润RKTSTE
| Q4 25 | $68.0M | $192.9M | ||
| Q3 25 | $-123.9M | $191.9M | ||
| Q2 25 | $-1.8M | $177.4M | ||
| Q1 25 | $-10.4M | $145.7M | ||
| Q4 24 | $33.9M | $173.5M | ||
| Q3 24 | $-22.0M | $150.0M | ||
| Q2 24 | $1.3M | $145.4M | ||
| Q1 24 | $16.2M | $-1.4M |
毛利率RKTSTE
| Q4 25 | — | 43.8% | ||
| Q3 25 | — | 44.2% | ||
| Q2 25 | — | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | 58.9% | 44.5% | ||
| Q3 24 | -8.4% | 43.6% | ||
| Q2 24 | 47.4% | 44.7% | ||
| Q1 24 | 51.2% | 40.2% |
营业利润率RKTSTE
| Q4 25 | 6.3% | 18.3% | ||
| Q3 25 | -11.5% | 18.2% | ||
| Q2 25 | 1.8% | 17.7% | ||
| Q1 25 | -21.5% | 14.6% | ||
| Q4 24 | 38.1% | 17.9% | ||
| Q3 24 | -76.9% | 16.5% | ||
| Q2 24 | 14.8% | 14.5% | ||
| Q1 24 | 21.6% | 22.0% |
净利率RKTSTE
| Q4 25 | 2.5% | 12.9% | ||
| Q3 25 | -7.7% | 13.1% | ||
| Q2 25 | -0.1% | 12.8% | ||
| Q1 25 | -1.0% | 9.8% | ||
| Q4 24 | 1.9% | 12.7% | ||
| Q3 24 | -3.4% | 11.3% | ||
| Q2 24 | 0.1% | 11.4% | ||
| Q1 24 | 1.2% | -0.1% |
每股收益（稀释后）RKTSTE
| Q4 25 | $0.10 | $1.96 | ||
| Q3 25 | $-0.06 | $1.94 | ||
| Q2 25 | $-0.01 | $1.79 | ||
| Q1 25 | $-0.08 | $1.48 | ||
| Q4 24 | $0.28 | $1.75 | ||
| Q3 24 | $-0.19 | $1.51 | ||
| Q2 24 | $0.01 | $1.46 | ||
| Q1 24 | $0.11 | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.7B | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $22.9B | $7.2B |
| 总资产 | $60.7B | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资RKTSTE
| Q4 25 | $2.7B | $423.7M | ||
| Q3 25 | $5.8B | $319.2M | ||
| Q2 25 | $5.1B | $279.7M | ||
| Q1 25 | $1.4B | $171.7M | ||
| Q4 24 | $1.3B | $155.2M | ||
| Q3 24 | $1.2B | $172.2M | ||
| Q2 24 | $1.3B | $198.3M | ||
| Q1 24 | $861.4M | $207.0M |
总债务RKTSTE
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $3.1B |
股东权益RKTSTE
| Q4 25 | $22.9B | $7.2B | ||
| Q3 25 | $8.9B | $7.0B | ||
| Q2 25 | $7.4B | $7.0B | ||
| Q1 25 | $8.6B | $6.6B | ||
| Q4 24 | $9.0B | $6.4B | ||
| Q3 24 | $8.4B | $6.6B | ||
| Q2 24 | $8.8B | $6.4B | ||
| Q1 24 | $8.6B | $6.3B |
总资产RKTSTE
| Q4 25 | $60.7B | $10.6B | ||
| Q3 25 | $33.6B | $10.4B | ||
| Q2 25 | $30.4B | $10.4B | ||
| Q1 25 | $25.3B | $10.1B | ||
| Q4 24 | $24.5B | $10.0B | ||
| Q3 24 | $25.1B | $10.2B | ||
| Q2 24 | $23.6B | $10.1B | ||
| Q1 24 | $22.2B | $11.1B |
负债/权益比RKTSTE
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2B | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.3B | $199.5M |
| 自由现金流率自由现金流/营收 | -47.2% | 13.3% |
| 资本支出强度资本支出/营收 | 1.5% | 6.6% |
| 现金转化率经营现金流/净利润 | -18.08× | 1.55× |
| 过去12个月自由现金流最近4个季度 | $-4.0B | $917.1M |
8季度趋势，按日历期对齐
经营现金流RKTSTE
| Q4 25 | $-1.2B | $298.2M | ||
| Q3 25 | $-50.3M | $287.8M | ||
| Q2 25 | $-1.9B | $420.0M | ||
| Q1 25 | $-797.0M | $260.8M | ||
| Q4 24 | $1.8B | $332.8M | ||
| Q3 24 | $-1.3B | $250.7M | ||
| Q2 24 | $-122.3M | $303.7M | ||
| Q1 24 | $-3.0B | $254.8M |
自由现金流RKTSTE
| Q4 25 | $-1.3B | $199.5M | ||
| Q3 25 | $-71.8M | $201.3M | ||
| Q2 25 | $-1.9B | $326.4M | ||
| Q1 25 | $-811.0M | $189.9M | ||
| Q4 24 | $1.8B | $243.6M | ||
| Q3 24 | $-1.4B | $148.8M | ||
| Q2 24 | $-138.3M | $195.7M | ||
| Q1 24 | $-3.0B | $163.3M |
自由现金流率RKTSTE
| Q4 25 | -47.2% | 13.3% | ||
| Q3 25 | -4.5% | 13.8% | ||
| Q2 25 | -137.2% | 23.5% | ||
| Q1 25 | -78.2% | 12.8% | ||
| Q4 24 | 103.1% | 17.8% | ||
| Q3 24 | -209.6% | 11.2% | ||
| Q2 24 | -10.6% | 15.3% | ||
| Q1 24 | -218.7% | 14.6% |
资本支出强度RKTSTE
| Q4 25 | 1.5% | 6.6% | ||
| Q3 25 | 1.3% | 5.9% | ||
| Q2 25 | 1.1% | 6.7% | ||
| Q1 25 | 1.4% | 4.8% | ||
| Q4 24 | 1.1% | 6.5% | ||
| Q3 24 | 2.9% | 7.7% | ||
| Q2 24 | 1.2% | 8.4% | ||
| Q1 24 | 1.0% | 8.2% |
现金转化率RKTSTE
| Q4 25 | -18.08× | 1.55× | ||
| Q3 25 | — | 1.50× | ||
| Q2 25 | — | 2.37× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | 54.42× | 1.92× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | -94.46× | 2.09× | ||
| Q1 24 | -185.80× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RKT
| Other | $1.4B | 51% |
| Direct To Customer Segment | $945.8M | 35% |
| Partner Network Segment | $216.7M | 8% |
| Subscription Revenue | $91.3M | 3% |
| Closing Fees | $47.1M | 2% |
| Appraisal Revenue | $10.7M | 0% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
